Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 9/20 | 0.54 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.39 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10035654 | 0.99 | TERT (0.55) | TERTTNKS2TSHRLMNAALOX15 | |
| SCHEMBL10001931 | 0.94 | TERT (0.51) | TERTTNKS2TSHRLMNAALOX15 | |
| SCHEMBL10001935 | 0.93 | TERT (0.47) | TERTTNKS2TSHRLMNAALOX15 | |
| SCHEMBL10001921 | 0.92 | TERT (0.48) | TERTTNKS2TSHRLMNAALOX15 | |
| SCHEMBL10001934 | 0.89 | TERT (0.49) | TERTTNKS2TSHRALOX15PAK1 | |
| SCHEMBL10035606 | 0.86 | TERT (0.52) | TERTTNKS2TSHRPAK1RAB9A | |
| SCHEMBL10001923 | 0.85 | TERT (0.41) | TERTTNKS2TSHRLMNAALOX15 | |
| SCHEMBL14367687 | 0.84 | TERT (0.48) | TERTLMNA | |
| SCHEMBL10001924 | 0.84 | TERT (0.41) | TERTTNKS2TSHRLMNAALOX15 | |
| SCHEMBL14530618 | 0.83 | TERT (0.39) | TERTTNKS2TSHRLMNAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110404-B2 | Luminescent lanthanide binding chelates | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-02-07 | — | — | US | disclosed |
| US-20080299675-A1 | Luminescent Lanthanide Binding Chelates | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2008-12-04 | — | — | US | disclosed |
| WO-2007055700-A1 | LUMINESCENT LANTHANIDE BINDING CHELATES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2007-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299675-A1 | Luminescent Lanthanide Binding Chelates | HLCS, LYAR, SLC6A13 | TERT 2908/4885TNKS2 3224/4885TSHR 512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.